Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Site JP00004, Aichi

Site JP00048, Aichi

Site JP00049, Aichi

Site JP00038, Chiba

Site JP00039, Chiba

Site JP00040, Chiba

Site JP00041, Chiba

Site JP00042, Chiba

Site JP00002, Fukuoka

Site JP00060, Fukuoka

Site JP00061, Fukuoka

Site JP00001, Hokkaido

Site JP00006, Hokkaido

Site JP00007, Hokkaido

Site JP00057, Hyōgo

Site JP00058, Hyōgo

Site JP00059, Hyōgo

Site JP00030, Kanagawa

Site JP00031, Kanagawa

Site JP00032, Kanagawa

Site JP00033, Kanagawa

Site JP00034, Kanagawa

Site JP00035, Kanagawa

Site JP00036, Kanagawa

Site JP00037, Kanagawa

Site JP00056, Kyoto

Site JP00003, Osaka

Site JP00050, Osaka

Site JP00051, Osaka

Site JP00052, Osaka

Site JP00053, Osaka

Site JP00054, Osaka

Site JP00055, Osaka

Site JP00043, Saitama

Site JP00044, Saitama

Site JP00045, Saitama

Site JP00046, Saitama

Site JP00047, Saitama

Site JP00005, Tokyo

Site JP00008, Tokyo

Site JP00009, Tokyo

Site JP00010, Tokyo

Site JP00011, Tokyo

Site JP00012, Tokyo

Site JP00013, Tokyo

Site JP00014, Tokyo

Site JP00015, Tokyo

Site JP00016, Tokyo

Site JP00017, Tokyo

Site JP00018, Tokyo

Site JP00019, Tokyo

Site JP00020, Tokyo

Site JP00021, Tokyo

Site JP00022, Tokyo

Site JP00023, Tokyo

Site JP00024, Tokyo

Site JP00025, Tokyo

Site JP00026, Tokyo

Site JP00027, Tokyo

Site JP00028, Tokyo

Site JP00029, Tokyo